# MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

> **NCT00482729** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1246 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** sitagliptin phosphate (+) metformin hydrochloride
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT00482729
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-19
- **Primary completion:** 2008-11-03
- **Final completion:** 2009-04-27
- **Target enrollment:** 1246 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482729, "MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00482729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*